|
Biotech
Wall Street Journal:
BOSTON (MarketWatch) -- Drug stocks trended lower in early trading Tuesday as shares of Shire Plc gained on news that it applied for European market approval for its new treatment for Gaucher disease.
. (Read More)
21 hours ago
Health News from Medical News Today:
Origin Agritech Limited (NASDAQ GS: SEED) ("Origin"), a leading technology-focused supplier of crop seeds and agri-biotech research in China, announced it has received the Bio-safety Certificate from the Ministry of Agricultu (Read More)
News Networks:
The Proteomics News Network,
Massage Therapy News And Insights
Topic:
Research
Wall Street Journal:
BOSTON (MarketWatch) -- Drug stocks advanced in early action Monday, boosted by a rally among major European drugmakers, while shares of Cephalon Inc. fell on news that a later-stage clinical study for its pediatric drug Cinq (Read More)
Wall Street Journal:
Drug stocks cling to the flat line in morning activity while shares of Inovio Biomedical soar on positive clinical data for its new DNA-based flu vaccine.
. (Read More)
Health News from Medical News Today:
American farmers have adopted genetically engineered (GE) crops widely since their introduction in 1996 because of the tangible benefits that biotech varieties deliver. According to the U.S. Department of Agriculture, U.S. (Read More)
News Network:
The Proteomics News Network
Health News from Medical News Today:
The Biotechnology Industry Organization (BIO) announces that Presidents Bill Clinton and George W. Bush, the 42nd and 43rd Presidents of the United States, will appear together for a moderated discussion at the 2010 BIO Inter (Read More)
News Network:
The Proteomics News Network
Topic:
Biotechnology
Wall Street Journal:
Allergan and Medicis Pharmaceutical Corp. lead drug stocks lower in morning activity as shares of the dermatology-products makers fall on news that the health-care reform bill put forth by Senate Democrats would levy a 5% tax (Read More)
www.guardian.co.uk:
A new, government-sponsored, awards scheme is helping to showcase the UK's innovation in science and green technologyDesigning traffic lights to be more energy efficient may not seem the hardest thing to do. Change the energy (Read More)
WSJ.com: PJ Main:
Money is pouring into biotech firms right now. That's bad news for investors, who are paying high prices for stocks that offer at best mixed results, writes Brett Arends. (Read More)
Wall Street Journal:
Drug stocks slip early Wednesday, while shares of Vivus jump on a positive Phase III clinical study for the company’s new erectile-dysfunction drug.
. (Read More)
Health News from Medical News Today:
Sirona Biochem Corp. (TSX-V: SBM), an emerging biotech company focused on diabetes and obesity drug development, says the latest results from a clinical trial with a competitor's SGLT Inhibitor demonstrates the major opportun (Read More)
News Networks:
Current Medical News,
The Proteomics News Network
Topic:
Diabetes
WSJ.com: Money:
Money is pouring into biotech firms right now. That's bad news for investors, who are paying high prices for stocks that offer at best mixed results, writes Brett Arends. (Read More)
Wall Street Journal:
Drug stocks dip in early action Tuesday, while shares of Alkermes gain on positive news about two of its substance-abuse therapies.
. (Read More)
Health News from Medical News Today:
Amunix, Inc. and Versartis, Inc. announced today that the scientific journal Nature Biotechnology has published a comprehensive paper entitled "A recombinant polypeptide extends the in vivo half-life of peptides and proteins (Read More)
News Network:
The Proteomics News Network
Topic:
Biotechnology
Reuters: Environment:
KANSAS CITY (Reuters) - The rapid adoption by U.S. farmers of genetically engineered corn, soybeans and cotton has promoted increased use of pesticides, an epidemic of herbicide-resistant weeds and more chemical residues in f (Read More)
Add something
|
|
|
|
|
